Pharmaconex is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Explore opportunities with our Matchmaking program
Pharmaconex Exhibition is offering this year a Matchmaking program which will benefit both its exhibitors and visitors. The program will target all our visitors to identify their needs and interests then to match these needs with the eligible exhibitors and to set their meetings during the 3 days of the exhibition, so that all our visitors will optimize their benefits from visiting the exhibition by setting pre-arranged targeted meetings with the Companies they would like to meet.
Why be part of our Matchmaking Program?
- A total of 800+ meetings have been arranged during Pharmaconex 2022
- Optimize your time during 3 days of the exhibition via targeted meetings
- Improve your meetings quality by sharing your needs beforehand and you will be matched with the right exhibitor
- Pre-arrange most of your meetings and have a prepared agenda
- Avoid wasting your time and Specify the topics you would like to discuss
Matchmaking mechanism
How it works?
1. Eligibility:
Purchasing, R&D, Supply Chain managers as well as Owners, Managing Directors, Distributors and Traders are welcome to participate in the program. * Buyers should have a direct authority to place orders, source new products, or have a significant influence on purchasing decisions.
2. Application:
Register your interest to attend as a Visitor by completing the form through the Register as a visitor button. Select the products you would like to source.
3. Selection:
One of our members will contact you to set the timings of the meetings with your preferred supplier.
4. Onsite match-making:
Meetings will be confirmed from both sides visitors and exhibitors.
Copyright © 2023. All rights reserved. Informa Markets, a trading division of Informa PLC.